ACOG Calls for Routine Cannabis Screening as Use Reaches 7% in Pregnancy – Fertility Plus
Fertility Plus shared a post on LinkedIn:
“Cannabis is linked to higher rates of preterm birth, low birth weight, and neurodevelopmental issues in babies. Many still think it’s safe—it’s not risk-free!
The American College of Obstetricians and Gynecologists (ACOG) now calls for universal screening of all reproductive-aged individuals for cannabis use during prepregnancy, pregnancy, and lactation. This shift responds to rising cannabis use—now up to 7% in pregnancy—amid nationwide legalization. Research confirms increased risks of preterm birth, low birth weight, and neurodevelopmental impacts in exposed infants. Clinicians are urged to use interviews and validated tools, avoiding biologic drug tests that can result in inequitable care. ACOG highlights the need for evidence-based counseling and risk-reduction strategies personalized to each patient.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 14, 2025, 07:08Leili Mohebnasab: How Metabolic Signals Shape Immune Tolerance and Placental Health
-
Dec 14, 2025, 06:53New Data on Assisted Hatching in Assisted Reproduction – C.L.A.R. Consulting
-
Dec 14, 2025, 04:40Murat Levent Dereli: Monochorionic-Monoamniotic Twin with Aberrant Vascular Anastomosis
-
Dec 14, 2025, 04:18Impact of Basic Income on Health – The Center for Social Development at Washington University in St. Louis
-
Dec 14, 2025, 04:14Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
-
Dec 14, 2025, 04:07Jacques Maas: Transformative Strategies for Endometriosis and Adenomyosis
-
Dec 14, 2025, 04:04Caroline Ford: Reflects on a Journey in Gynaecological Cancer
-
Dec 14, 2025, 04:00Economic Impact of Endometriosis in New Zealand Revealed – Endometriosis New Zealand
-
Dec 14, 2025, 03:57Lone Hummelshoj: Exploring Experimental Models in Endometriosis and Adenomyosis
